Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Qi Zhou

机构：Beijing Institute of Technology, Nanchang University, Sun Yat-sen University, Chongqing University, Guangxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Institute (WIA), Soochow University, First Affiliated Hospital of Jiangxi Medical College, Shanghai University of Traditional Chinese Medicine, Huadong Hospital, Second Affiliated Hospital of Nanchang University, First Affiliated Hospital of GuangXi Medical University, The First Affiliated Hospital, Sun Yat-sen University, Shanghai Traditional Chinese Medicine Hospital, Seventh People's Hospital of Shanghai, Guangdong Academy of Medical Sciences, Punan Hospital, First Affiliated Hospital of Soochow University, Chongqing Cancer Hospital, Shanghai Zhabei District Shibei Hospital, Pudong New Area People's Hospital · ORCID：0000-0001-5673-4263

发表论文 175 篇 · 总被引 4311 次 · h-index 35

代表论文

  • First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial (2024 · Journal of Clinical Oncology · 被引 63)
  • Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes (2025 · Journal of Translational Medicine · 被引 31)
  • Comparative Metabolome and Transcriptome Analysis Revealed the Accumulative Mechanism of Rubusoside in Chinese Sweet Tea (2024 · Journal of Agricultural and Food Chemistry · 被引 12)
  • Pathogenesis and treatment of obesity-related polycystic ovary syndrome (2025 · Journal of Ovarian Research · 被引 9)
  • IBI354, an anti-HER2 antibody-drug conjugate, in patients with locally advanced unresectable or metastatic ovarian cancers: Updated results from a phase I trial. (2025 · Journal of Clinical Oncology · 被引 5)
  • Development of a predictive nomogram for testicular sperm extraction outcomes in patients with non-obstructive azoospermia using testicular volume, follicle-stimulating hormone levels, and testosterone levels as key parameters (2025 · Translational Andrology and Urology · 被引 5)